Literature DB >> 17565718

Akt2 is implicated in skeletal muscle differentiation and specifically binds Prohibitin2/REA.

Lisa Héron-Milhavet1, Daria Mamaeva, Anne Rochat, Ned J C Lamb, Anne Fernandez.   

Abstract

Akt1 and Akt2 are the major isoforms of Akt expressed in muscle cells and muscle tissue. We have performed siRNA silencing of Akt1 and Akt2 in C2 myoblasts to characterize their specific implication in muscle differentiation. Whereas silencing Akt2, and not Akt1, inhibited cell cycle exit and myoblast differentiation, Akt2 overexpression led to an increased proportion of differentiated myoblasts. In addition, we demonstrate that Akt2 is required for myogenic conversion induced by MyoD overexpression in fibroblasts. We show Akt2, but not Akt1, binds Prohibitin2/Repressor of Estrogen Activator, PHB2/REA, a protein recently implicated in transcriptionnal repression of myogenesis. Co-immunoprecipitation experiments on endogenous proteins showed the Akt2-REA complex does not contain Prohibitin1. We have analyzed expression and localization of PHB2/REA during proliferation and differentiation of mouse and human myoblasts. PHB2/REA shows punctated nuclear staining which partially co-localizes with Akt2 in differentiated myotubes and PHB2 levels decrease at the onset of myogenic differentiation concomitant with an increase in Akt2. There appears to be an inverse correlation between Akt2 and PHB2 protein levels where cells silenced for Akt2 expression show increased level of PHB2/REA and overexpression of Akt2 resulted in decreased Prohibitin2/REA. Taken together, these results, along with our previous observations, clearly show that Akt2 and not Akt1 plays a major and early role in cell cycle exit and myogenic differentiation and this function involves its specific interaction with PHB2/REA. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17565718     DOI: 10.1002/jcp.21177

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  23 in total

1.  Oxidation of Akt2 kinase promotes cell migration and regulates G1-S transition in the cell cycle.

Authors:  Revati Wani; N Sharmila Bharathi; Jeffrey Field; Allen W Tsang; Cristina M Furdui
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

Review 2.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

3.  The mTORC2 complex regulates terminal differentiation of C2C12 myoblasts.

Authors:  Lili Shu; Peter J Houghton
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

4.  Role of phosphatidylinositol 3,4,5-trisphosphate (PIP3) 5-phosphatase skeletal muscle- and kidney-enriched inositol polyphosphate phosphatase (SKIP) in myoblast differentiation.

Authors:  Takeshi Ijuin; Tadaomi Takenawa
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

5.  Protein phosphatase 2A isoforms utilizing Aβ scaffolds regulate differentiation through control of Akt protein.

Authors:  Justin H Hwang; Tao Jiang; Shreya Kulkarni; Nathalie Faure; Brian S Schaffhausen
Journal:  J Biol Chem       Date:  2013-09-19       Impact factor: 5.157

6.  Prohibitin-2 binding modulates insulin-like growth factor-binding protein-6 (IGFBP-6)-induced rhabdomyosarcoma cell migration.

Authors:  Ping Fu; Zhiyong Yang; Leon A Bach
Journal:  J Biol Chem       Date:  2013-09-03       Impact factor: 5.157

7.  Recent insights into the actions of IGFBP-6.

Authors:  Leon A Bach
Journal:  J Cell Commun Signal       Date:  2015-03-26       Impact factor: 5.782

8.  Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation.

Authors:  Peter Rotwein; Elizabeth M Wilson
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

9.  Strain-induced proliferation requires the phosphatidylinositol 3-kinase/AKT/glycogen synthase kinase pathway.

Authors:  Christopher P Gayer; Lakshmi S Chaturvedi; Shouye Wang; David H Craig; Thomas Flanigan; Marc D Basson
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

10.  Inhibition of myogenesis by Notch: evidence for multiple pathways.

Authors:  Matthew F Buas; Shara Kabak; Tom Kadesch
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.